EUVIMEDEUVIMED entdecken
Crossref

Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug‐Resistant Bacteria

Rayid Abdulqawi iD, Rana A Saleh iD, Reem M Alameer, Roaa Alabiri, Ruba Alabiri, Khaled Alkattan, Reem S Almaghrabi iD, Zainab Al Duhailib, Sahar Althawadi, Najib M Rahman, Waleed Saleh, Amani H Yamani und 1 weitere

Transplant Infectious Disease · 2025

DOI: 10.1111/tid.14446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Rayid Abdulqawi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lung Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Lung Transplantation, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Antibiotic Prophylaxis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Twenty percent of lung donors in our transplant program carry respiratory carbapenem‐resistant (CR) gram‐negative bacteria (GNB), most commonly CR Acinetobacter baumannii . Universal multiplex panel testing of lung transplant donors was introduced in June 2022 as a strategy to expedite CR‐GNB detection and optimize perioperative antibiotic prophylaxis. We herein describe our experiences with this approach.

Methods

Retrospective single‐center cohort study including 53 adult patients who underwent lung‐only transplantation between June 2022 and December 2023.

Results

The most common bacteria identified by the multiplex panel were Staphylococcus aureus ( n = 20), A. baumannii ( n = 13), Klebsiella pneumoniae ( n = 13), and Pseudomonas aeruginosa ( n = 10). The panel detected 6/9 A. baumannii , 2/2 CR K. pneumoniae , 1/1 CR P. aeruginosa , and 7/8 methicillin‐resistant S. aureus that were grown on conventional cultures, corresponding to negative predictive values of 94%, 100%, 100%, and 98%. Based on panel or culture results, IV tigecycline was administered as prophylaxis in 19% of patients, colistin in 17%, and novel beta‐lactams in 15%.

Conclusion

The multiplex panel rapidly detected donor CR‐GNB with a high negative predictive value and resulted in clinical effects of reducing broad‐spectrum antibiotic prescriptions and maintaining adequate posttransplant outcomes. Prospective studies with predefined outcomes are needed to compare panel‐directed therapy against current standards of care. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialAntibiotic ProphylaxisHumansRetrospective StudiesMaleMiddle AgedFemaleAdultTissue DonorsAgedGram-Negative BacteriaLung

Stichwörter der Autor:innen

carbapenem‐resistant Acinetobacter baumanniicarbapenem‐resistant klebsiella pneumoniadonor‐derived infectionlung transplantation

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Lung Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Section of Transplant Infectious Diseases, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Critical Care Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Pathology & Laboratory Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

ORCID-Profile: Rayid Abdulqawi, Rana A Saleh, Reem S Almaghrabi

Zitieren

APA

Abdulqawi, R., Saleh, R. A., Alameer, R. M., Alabiri, R., Alabiri, R., Alkattan, K., Almaghrabi, R. S., Duhailib, Z. A., Althawadi, S., Rahman, N. M., Saleh, W., Yamani, A. H., & Al-Mutairy, E. A. (2025). Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug‐Resistant Bacteria. Transplant Infectious Disease. https://doi.org/10.1111/tid.14446

Vancouver

Abdulqawi R, Saleh RA, Alameer RM, Alabiri R, Alabiri R, Alkattan K, et al. Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug‐Resistant Bacteria. Transplant Infectious Disease. 2025. doi:10.1111/tid.14446

BibTeX
@article{Abdulqawi2025,
  author = {Abdulqawi, Rayid and Saleh, Rana A and Alameer, Reem M and Alabiri, Roaa and Alabiri, Ruba and Alkattan, Khaled and Almaghrabi, Reem S and Duhailib, Zainab Al and Althawadi, Sahar and Rahman, Najib M and Saleh, Waleed and Yamani, Amani H and Al-Mutairy, Eid A},
  title = {Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis Against Multidrug‐Resistant Bacteria},
  journal = {Transplant Infectious Disease},
  year = {2025},
  doi = {10.1111/tid.14446}
}
Kostenlos starten →